Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing

Journal of Infection and Chemotherapy

Volumn 16, Issue 5, 2010, Pages 322-328

  Gülmez, Dolunay ^a   Çakar, Asli ^a   Şener, Burçin ^a   Karakaya, Jale ^a   Hasçelik, Gülşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Comparative study; Drug resistance; E test; Stenotrophomonas maltophilia; Synergy test

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TIMENTIN;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATION; BROTH DILUTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISK DIFFUSION; DRUG EFFICACY; DRUG POTENTIATION; EPSILOMETER TEST; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRACTICE GUIDELINE; STENOTROPHOMONAS MALTOPHILIA;

EID: 78149406112     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0068-2     Document Type: Article

References (31)

1. M Denton KG Kerr 1998 Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin Microbiol Rev 11 57 80 9457429
2. AC Gales RN Jones KR Forward J Linares HS Sader J Verhoef 2001 Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) Clin Infect Dis 32 Suppl 2 S104 S113 10.1086/320183 11320451
3. L Zhang XZ Li K Poole 2000 Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system Antimicrob Agents Chemother 44 287 293 10.1128/AAC.44.2.287-293.2000 10639352 (Pubitemid 30060721)
4. XZ Li L Zhang K Poole 2002 SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia Antimicrob Agents Chemother 46 333 343 10.1128/AAC.46.2.333-343.2002 11796339 (Pubitemid 34087177)
5. CLSI. Performance standards for antimicrobial susceptibility testing. Nineteenth information supplement, CLSI document M100-S19. Wayne, PA: Clinical Laboratory Standards; 2009.
6. KC Carroll S Cohen R Nelson DM Campbell JD Claridge MW Garrison, et al. 1998 Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia Diagn Microbiol Infect Dis 32 229 235 10.1016/S0732-8893(98)00089-3 9884841 (Pubitemid 29017744)
7. P Joyanes M del Carmen Conejo L Martinez-Martinez EJ Perea 2001 Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples J Clin Microbiol 39 3247 3253 10.1128/JCM.39.9.3247-3253. 2001 11526158 (Pubitemid 32830322)
8. E Stefaniuk A Baraniak M Gniadkowski W Hryniewicz 2003 Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice Eur J Clin Microbiol Infect Dis 22 479 485 10.1007/s10096-003-0962-y 12884060 (Pubitemid 37100595)
9. Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman's color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippinncott Williams & Wilkins; 2006.
10. D Gulmez G Hascelik 2005 Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital Clin Microbiol Infect 11 880 886 10.1111/j.1469-0691.2005.01257.x 16216102 (Pubitemid 41535924)
11. FC Tenover RD Arbeit RV Goering PA Mickelsen BE Murray DH Persing, et al. 1995 Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 2233 2239 7494007
12. CLSI. Performance standards for antimicrobial susceptibility testing. Seventeenth information supplement. CLSI Document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
13. ME Pachon-Ibanez ME Jimenez-Mejias C Pichardo AC Llanos J Pachon 2004 Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem Antimicrob Agents Chemother 48 4479 4481 10.1128/AAC.48.11.4479-4481.2004 15504889 (Pubitemid 39434923)
14. R Insa E Cercenado MJ Goyanes A Morente E Bouza 2007 In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia J Antimicrob Chemother 59 583 585 10.1093/jac/dkl496 17213264 (Pubitemid 47073476)
15. White RL BD M Manduru JA Bosso 1996 Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard and E-test Antimicrobial Agents Chemother 40 1914 1918
16. Satish KP, MR, Eliopulos GM. Antimicrobial combinations. In: Lorien V, editor. Antibiotics in laboratory medicine. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 365-440.
17. National Committee for Clinical Laboratory Standards N. Development of In vitro susceptibility testing criteria and quality control parameters: approved standard M23-A2. Wayne: NCCLS; 2000.
18. FDA. Class II special controls guidance document: antimicrobial susceptibility test (AST) systems; guidance for Industry and FDA. US Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health; 2007.
19. C Betriu A Sanchez ML Palau M Gomez JJ Picazo 2001 Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999 J Antimicrob Chemother 48 152 154 10.1093/jac/48.1.152 11418532
20. S Valdezate A Vindel E Loza F Baquero R Canton 2001 Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains Antimicrob Agents Chemother 45 1581 1584 10.1128/AAC.45.5.1581-1584.2001 11302834 (Pubitemid 32374141)
21. O Koseoglu B Sener D Gulmez B Altun D Gur 2004 Stenotrophomonas maltophilia as a nosocomial pathogen New Microbiol 27 273 279 15460530
22. DJ Hoban SK Bouchillon BM Johnson JL Johnson MJ Dowzicky 2005 In vitro activity of tigecycline against 6792 gram-negative and gram-positive clinical isolates from the global tigecycline evaluation and surveillance trial (TEST Program, 2004) Diagn Microbiol Infect Dis 52 215 227 10.1016/j.diagmicrobio. 2005.06.001 16105567 (Pubitemid 41133548)
23. Pankuch GA JM SF Rittenhouse PC Appelbaum 1994 Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods Antimicrobial Agents Chemother 38 2317 2322
24. M Tatman-Otkun S Gurcan B Ozer B Aydoslu S Bukavaz 2005 The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness BMC Microbiol 5 24 10.1186/1471-2180-5-24 15882456 (Pubitemid 40958324)
25. TS Krueger EA Clark DE Nix 2001 In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations Diagn Microbiol Infect Dis 41 71 78 10.1016/S0732-8893(01)00281-4 11687317 (Pubitemid 33001462)
26. TY Tan SY Ng 2007 Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin Clin Microbiol Infect 13 541 544 10.1111/j.1469-0691.2007.01708.x 17371537 (Pubitemid 46563506)
27. I Galani F Kontopidou M Souli PD Rekatsina E Koratzanis J Deliolanis, et al. 2008 Colistin susceptibility testing by Etest and disk diffusion methods Int J Antimicrob Agents 31 434 439 10.1016/j.ijantimicag.2008.01.011 18328674
28. AC Nicodemo MR Araujo AS Ruiz AC Gales 2004 In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods J Antimicrob Chemother 53 604 608 10.1093/jac/dkh128 14973153 (Pubitemid 38499774)
29. ME Falagas PE Valkimadi YT Huang DK Matthaiou PR Hsueh 2008 Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review J Antimicrob Chemother 62 889 894 10.1093/jac/dkn301 18662945
30. CD Poulos SO Matsumura BM Willey DE Low A McGeer 1995 In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia Antimicrob Agents Chemother 39 2220 2223 8619571
31. SJ Liaw LJ Teng PR Hsueh SW Ho KT Luh 2002 In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia J Formos Med Assoc 101 495 501 12353342